Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Opthea ( (AU:OPT) ) has provided an announcement.
Opthea Limited has released its Corporate Governance Statement for the financial year ending June 30, 2025. The statement, approved by the board and current as of September 15, 2025, outlines the company’s adherence to the ASX Corporate Governance Council’s recommendations. This disclosure is crucial for maintaining transparency and accountability, impacting Opthea’s operations and positioning within the industry by ensuring compliance with regulatory standards.
The most recent analyst rating on (AU:OPT) stock is a Sell with a A$0.05 price target. To see the full list of analyst forecasts on Opthea stock, see the AU:OPT Stock Forecast page.
More about Opthea
Opthea Limited operates in the biotechnology industry, focusing on developing and commercializing therapies for eye diseases, particularly those related to retinal conditions.
YTD Price Performance: -25.93%
Technical Sentiment Signal: Sell
Current Market Cap: A$738.8M
See more insights into OPT stock on TipRanks’ Stock Analysis page.